Hepatitis B treatment vaccine with inactivated total recombinant Hansenula polymorpha cells expressing HBsAg

摘要

HBsAg expressed in cells of recombinant Hansenula polymorpha, containing 6-10 μg HBsAg as antigen in 10 ⁸ cells, containing a total of 16-21 HBsAg-specific CTL epitopes and optimized inactivity A vaccine for treating hepatitis B by inactivated total recombinant Hansenula polymorpha cells expressing HBsAg, using adjuvanted total recombinant Hansenula polymorpha cells.